NCT04756726 2026-03-25Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple MyelomaC4 Therapeutics, Inc.Phase 1 Active not recruiting224 enrolled